切换至 "中华医学电子期刊资源库"

中华损伤与修复杂志(电子版) ›› 2020, Vol. 15 ›› Issue (03) : 231 -234. doi: 10.3877/cma.j.issn.1673-9450.2020.03.017

所属专题: 文献

护理园地

胰岛素在多腔袋肠外营养液中的稳定性研究
李磊1, 刘鹏1, 李明2, 赵婉妮1, 潘琦2, 朱明炜1,(), 韦军民1   
  1. 1. 100730 北京医院 国家老年医学中心普通外科
    2. 100730 北京医院 国家老年医学中心内分泌科
  • 收稿日期:2020-03-22 出版日期:2020-06-01
  • 通信作者: 朱明炜
  • 基金资助:
    北京市科学技术委员会重点项目(D18110ff300218004)

Experimental study on the stability of insulin in parenteral nutrition in multi-cavity bag

Lei Li1, Peng Liu1, Ming Li2, Wanni Zhao1, Qi Pan2, Mingwei Zhu1,(), Junmin Wei1   

  1. 1. Department of General Surgery, Beijing Hospital, National Geriatrics Center, Beijing 100730, China
    2. Department of Endocrine, Beijing Hospital, National Geriatrics Center, Beijing 100730, China
  • Received:2020-03-22 Published:2020-06-01
  • Corresponding author: Mingwei Zhu
  • About author:
    Corresponding author: Zhu Mingwei, Email:
引用本文:

李磊, 刘鹏, 李明, 赵婉妮, 潘琦, 朱明炜, 韦军民. 胰岛素在多腔袋肠外营养液中的稳定性研究[J/OL]. 中华损伤与修复杂志(电子版), 2020, 15(03): 231-234.

Lei Li, Peng Liu, Ming Li, Wanni Zhao, Qi Pan, Mingwei Zhu, Junmin Wei. Experimental study on the stability of insulin in parenteral nutrition in multi-cavity bag[J/OL]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2020, 15(03): 231-234.

目的

探讨胰岛素在多腔袋肠外营养液中的稳定性。

方法

2018年1月至3月于北京医院国家老年医学中心进行胰岛素体外对照实验研究,分为3组:多腔袋组、院内配置组、葡萄糖组。多腔袋组使用工业化多腔袋肠外营养制剂[脂肪乳氨基酸(17)葡萄糖(10%)注射液,每袋均含葡萄糖97 g,大豆油长链甘油三酯51 g,氨基酸34 g,液体总量1 440 mL,乙烯-醋酸乙烯共聚物(EVA)袋];院内配置组为自配型肠外营养液(总量1 500 mL,含20%长链脂肪乳剂250 mL,8.6%复方18种氨基酸500 mL,50%葡萄糖溶液250 mL,0.9%氯化钠溶液500 mL等,EVA袋);葡萄糖组为10%葡萄糖注射液1 000 mL,使用苯乙烯、乙烯、丁烯共聚物(SEB)袋,加入15%氯化钾1.5 g;每组各10袋。分别加入精蛋白生物合成人胰岛素10、20、30、40、50 IU,混匀后静置30 min,模拟临床应用模式体外匀速输注12 h,分别测定混匀后即刻,输注前,输注2、4、6、8、10、12 h肠外营养液中胰岛素浓度;计算加入胰岛素10、50 IU 3组不同时相点胰岛素浓度变化值与变化幅度。

结果

标准操作规范下,添加胰岛素剂量10 IU,多腔袋组混匀后即刻,输注前,输注2、4、6、8、10、12 h肠外营混合液中胰岛素浓度分别为1 375、1 355、1 290、1 215、1 260、1 270、1 310、1 275 μU/mL;添加胰岛素量50 IU,多腔袋组混匀后即刻,输注前,输注2、4、6、8、10、12 h肠外营养混合液中胰岛素浓度分别为4 710、4 675、4 915、4 525、4 805、4 575、4 805、4 570 μU/mL。加入胰岛素10 IU,多腔袋组输注前,输注2、4、6、8、10、12 h对应的胰岛素浓度变化值分别为-20、-85、-160、-115、-65、-100 μU/mL;加入胰岛素50 IU,多腔袋组输注前,输注2、4、6、8、10、12 h对应的胰岛素浓度变化值分别为-35、205、-185、95、-135、95、-140 μU/mL。加入胰岛素10 IU,多腔袋组输注前,输注2、4、6、8、10、12 h对应的的胰岛素浓度变化幅度分别为1.5%、6.2%、11.6%、8.4%、7.6%、4.7%、7.3%;加入胰岛素50 IU,多腔袋组输注前,输注2、4、6、8、10、12 h对应的胰岛素浓度变化幅度分别为0.7%、4.4%、3.9%、2.0%、2.9%、2.0%、3.0%。多腔袋组不同时相点胰岛素浓度较为稳定,不受胰岛素加入剂量和使用时间的影响;院内配置组胰岛素浓度变化趋势与多腔袋组相似;葡萄糖组胰岛素浓度稳定性尚好,但相对浓度低于前2者水平。

结论

胰岛素在多腔袋肠外营养制剂中稳定性较好,不受浓度和时间影响。

Objective

To study the stability of insulin in parenteral nutrition in multi-cavity bag.

Methods

From January to March 2018, a comparative study of insulin in vitro was conducted and divided into 3 groups (multi-cavity bag group, hospital configuration group, glucose group) in Beijing Hospital, National Geriatrics Center. Multi-cavity bag group was injected with the parenteral nutrition in multi-cavity bag [Fat milk amino acid (17) glucose (10%) injection, each bag contains glucose 97 g, soybean oil long-chain triglyceride 51 g, amino acid 34 g, total liquid 1 440 mL, ethylene vinyl acetate (EVA) bag]. Hospital configuration group was injected with self-made PN mixture (1 500 mL volume in total, containing 250 mL 20% long-chain fat emulsion, 500 mL 8.6% compound 18 amino acids, 250 mL 50% glucose, 500 mL 0.9% sodium chloride solution, EVA bag). Glucose group was injected with 1 000 mL 10% glucose injection, styrene, ethylene, butene copolymer [styrene ethylene butene copolymer (SEB)] bags were used, 15% potassium chloride 1.5 g was added. Ten bags were in each group which was added with protamine biosynthetic human insulin of 10, 20, 30, 40 and 50 IU, stimulating the clinical infusion of 12 hours in constant speed in vitro. After mixing, insulin concentration of multi-cavity bag was detected in the time of immediately after mixing, before infusion, 2, 4, 6, 8, 10 and 12 h after infusion. The change value and amplitude of insulin concentration at different time points in 3 groups with insulin 10 and 50 IU were calculated.

Results

Under the standard operation specifications, added insulin dose of 10 IU, immediately after mixing in the multi-cavity bag group, before infusion, 2, 4, 6, 8, 10, and 12 h after infusion were 1 375, 1 355, 1 290, 1 215, 1 260, 1 270, 1 310 and 1 275 μU/mL; 50 IU of insulin was added, the insulin concentration in the time of immediately after mixing, before infusion, 2, 4, 6, 8, 10 and 12 h after infusion were 4 710, 4 675, 4 915, 4 525, 4 805, 4 575, 4 805, 4 570 μU/mL. Ten IU of insulin was added, the change values of insulin concentration in the time of before infusion, 2, 4, 6, 8, 10 and 12 h after infusion were -20, -85, -160, -115, -65 and -100 μU/mL, respectively. Fifty IU of insulin was added, the change values of insulin concentration in the time of before infusion, 2, 4, 6, 8, 10 and 12 h after infusion were -35, 205, -185, 95, -135, 95 and -140 μU/mL, respectively. Ten IU of insulin was added, the rangeability of insulin concentration in the time of before infusion, 2, 4, 6, 8, 10 and 12 h after infusion were 1.5%, 6.2%, 11.6%, 8.4%, 7.6%, 4.7% and 7.3%, respectively. Fifty IU of insulin was added, the rangeability of insulin concentration in the time of before infusion, 2, 4, 6, 8, 10 and 12 h after infusion were 0.7%, 4.4%, 3.9%, 2.0%, 2.9%, 2.0% and 3.0%, respectively. The insulin concentration in different time of the multi-cavity bag group was stable, and was not affected by the dosage and using time of insulin. The change trend of insulin concentration in the hospital group was similar to that in the multi-cavity bag group. The insulin in glucose group was stable with time, while the relative concentration was lower than those in the other two groups.

Conclusion

The stability of insulin in anteriorly pouch parenteral nutrition preparation is good, and is not affected by the concentration or time.

表1 加入不同剂量胰岛素,混合后即刻、输注前及输注不同时相点3组肠外营养液中胰岛素浓度(μU/mL)
图1 加入胰岛素10 IU,在体外输注不同时相点3组肠外营养液中胰岛素浓度变化值
图2 加入胰岛素50 IU,在体外输注不同时相点3组肠外营养液中胰岛素浓度变化值
图3 加入胰岛素10 IU,在体外输注不同时相点3组肠外营养液中胰岛素浓度变化幅度
图4 加入胰岛素50 IU,在体外输注不同时相点3组肠外营养液中胰岛素浓度变化幅度
[1]
Wei J, Chen W, Zhu M, et al. Guidelines for parenteral and enteral nutrition support in geriatric patients in China[J].Asia Pac J Clin Nutr, 2015, 24(2): 336-346.
[2]
A.S.P.E.N. Practice Management Task Force, Mark Delegge, Jennifer A Wooley, et al. The State of Nutrition Support Teams and Update on Current Models for Providing Nutrition Support Therapy to Patients[J]. Nutr Clin Pract, 2010, 25(1): 76-84.
[3]
Dorothee V, Anne MB, Tommy C, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics(2018)[EB/OL].(2018-05-24) [2020-02-16].

URL    
[4]
中华医学会. 临床诊疗指南-肠外肠内营养学分册[M]. 北京:人民卫生出版社,2008: 176.
[5]
中华医学会肠外肠内营养学分会. 补充性肠外营养中国专家共识[J]. 中华胃肠外科杂志,2017, 20(1): 9-14.
[6]
王希,姜海平. 胰岛素直接加入全营养混合液对肠外营养病人血糖水平的影响[J]. 肠外与肠内营养,2006, 13(4):203-207.
[7]
叶向红,张中书,王新颖,等. 胰岛素不同配置时间和方法对其有效浓度的影响[J]. 肠外与肠内营养,2005, 12(1): 17-19.
[8]
Luboš Sobotka. 临床营养基础(第四版)[M]. 蔡威泽. 上海:上海交通大学出版社,2013: 390.
[9]
Taylor BE, McClave SA, Martindale RG, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)[J]. Crit Care Med, 2016, 44(2): 390-438.
[10]
冷芸坤. 糖尿病患者肠外营养中胰岛素输注方式对血糖影响的对照研究[J]. 实用临床医学,2013, 14(2): 121-124.
[11]
中华医学会肠外肠内营养学分会. 成人围手术期营养支持指南[J]. 中华外科杂志,2016, 54(9): 641-647.
[12]
李磊,李欣,朱明炜. 肠外营养静脉输注途径的规范应用[J]. 中华临床营养杂志,2018, 26(2): 115-119.
[1] 王招娣, 孙丽丽, 温佩婷, 吴坤. 成人肠外营养患者住院期间胰岛素添加管理的证据总结[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(01): 32-38.
[2] 钟雅雯, 王煜, 王海臻, 黄莉萍. 肌苷通过抑制线粒体通透性转换孔开放缓解缺氧/复氧诱导的人绒毛膜滋养层细胞凋亡[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 525-533.
[3] 贾蔓箐, 卞婧, 周业平. 对小剂量胰岛素局部注射促进脂肪干细胞移植成活及改善糖尿病创面愈合临床观察[J/OL]. 中华损伤与修复杂志(电子版), 2023, 18(04): 312-316.
[4] 闫凯悦, 邓慧玲, 张玉凤, 宋鹤, 陈媛, 席淼. 胰岛素样生长因子-1与手足口病重症化的相关性研究[J/OL]. 中华实验和临床感染病杂志(电子版), 2023, 17(03): 151-157.
[5] 王本泉, 崔凡, 邱钧, 项本宏. 不同甲状腺手术方式对改善胰岛素抵抗的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(02): 208-211.
[6] 周玲, 吴园明. 复方异丙托溴铵对AECOPD患者肺功能及血清IGF-Ⅱ、SOD水平的影响[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(01): 103-106.
[7] 晏婷, 梁瑶瑶, 陈津. 干细胞衍生的胰岛素分泌细胞治疗糖尿病的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2023, 13(06): 355-362.
[8] 程柏凯, 杨光. 高胰岛素-正葡萄糖钳夹技术评估慢性肾脏病患者胰岛素抵抗的研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 334-339.
[9] 孙琳, 韩萍萍, 张碧琳, 张军霞. 血清WISP1水平与2型糖尿病患者血尿酸升高的相关性[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 178-182.
[10] 王嘉琳, 宋青. 妊娠合并胰岛素抵抗诊治的研究进展[J/OL]. 中华产科急救电子杂志, 2024, 13(01): 29-32.
[11] 何玉花, 钟欢妹, 王文惠, 沈永棋, 刘映云, 顾国威, 陈丹娜. 不同表型多囊卵巢综合征患者代谢指标及肥胖相关指标对多囊卵巢综合征合并代谢综合征人群的诊断效能分析[J/OL]. 中华临床实验室管理电子杂志, 2024, 12(04): 212-220.
[12] 高明生, 张盼盼, 包楠迪, 孟繁森, 李婷婷, 徐世平. 一种新型乳链菌素混合物体外杀灭幽门螺杆菌的实验研究[J/OL]. 中华胃肠内镜电子杂志, 2023, 10(04): 258-263.
[13] 张杨杨, 项楚淇, 朱满生. 肌少性肥胖与非酒精性脂肪性肝病间的关系以及研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 276-282.
[14] 吴晓明, 翟仰魁, 王娟, 张硕, 许杰, 潘从清. 男性2 型糖尿病患者空腹C 肽和定量胰岛素敏感性检测指数与血浆致动脉粥样硬化指数的相关性[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 288-294.
[15] 崔磊, 徐东升. 减重手术治疗肥胖患者胰岛素抵抗的研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 127-132.
阅读次数
全文


摘要